Cite

HARVARD Citation

    Liu, Y. et al. (2017). MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2. Scientific reports. 7 (1), pp. 1-9. [Online]. 
  
Back to record